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Background: The purpose of this study was to evaluate the applicability and variability of 
echographic imaging using 10 mHz and high-resolution 20 mHz B scanning for measurement 
of intraocular tumors.
Methods: This prospective consecutive study comprises 27 eyes in 27 patients with uveal 
melanoma. Each patient was examined by three experienced examiners independently on three 
occasions within a two-week time frame in a blinded manner. The height of the lesion was mea-
sured by all examiners using the 10 mHz B, 20 mHz B, and 8 mHz A scan probes. Additionally, 
basal diameter was examined using the 10 and 20 mHz B scan.
Results: Tumor height measurements for all examiners using the standardized A scan tended 
to be higher than for both B scan measurements. Statistical analysis revealed significant dif-
ferences in tumor height between B and A scan measurements. No difference in tumor height 
was found between the two B scan techniques (P = 0.239). Basal tumor diameter measurements 
revealed significant differences between 10 mHz and 20 mHz B scans (P , 0.001 and P = 0.001, 
respectively). For the 10 mHz B scan, basal diameter results tended to be larger than for the 
20 mHz B scan. No difference was found for interobserver variation in all A scan and B scan 
examinations. The mean standard deviation of the difference in tumor height measurements 
between the examiners was ±0.24 mm for the 8 mHz A scan, ±0.46 mm for the 10 mHz B scan, 
and ±0.42 mm for the 20 mHz B scan. Both the 10 mHz and more precise 20 mHz B scan 
  evaluations underestimated tumor height.
Conclusion: The 20 mHz ultrasound probe, despite its theoretically higher resolution, is not 
able to replace A scan measurements of tumor height.
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Introduction
Ophthalmic ultrasound plays a pivotal role in the diagnosis and follow-up of intraocular 
tumors. Basal tumor diameter, tumor height, and tumor volume are considered to be 
important prognostic indicators, especially in choroidal melanoma, the most common 
primary intraocular malignancy in adults.1–3
Standardized echography is a common and inexpensive technique for biometry and 
measuring intraocular tumors. This technique was introduced by Ossoinig in the 1960s. 
Standardized echography refers to a special examination technique which combines 
the use of a standardized A scan instrument developed for tissue differentiation and 
a real-time contact B scan. The standardized A scan is characterized by both internal 
(special signal processing through defined parameters) and external (ascertainment of 
the tissue sensitivity setting by the examiner) standardization, as well as a predefined Clinical Ophthalmology 2011:5 submit your manuscript | www.dovepress.com
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A scan and B scan examination of the globe.4 In standardized 
echography, an 8 mHz A scan probe is used for measuring 
tumor height and a 10 mHz B scan probe is used for the tumor 
base and topographic and morphological evaluation.
Since its inception, B scan ophthalmic ultrasound has 
employed frequencies near 10 mHz, providing good general-
purpose imaging of the vitreous, posterior coats, and the 
anterior orbit. In the 1990s, instruments utilizing higher 
frequencies were implemented for imaging of the anterior 
segment and posterior pole of the eye.5,6 Recently, the new 
technical development of sensitive broadband 20 mHz trans-
ducers has allowed higher frequencies to be used for imaging 
the posterior globe. The 75 µm wavelength of ultrasound at 
20 mHz is half the wavelength of a 10 mHz transducer, and 
therefore is theoretically capable of providing a two-fold 
improvement in resolution. Because the 20 mHz transducer 
has now become more popular, the aim of our study was to 
investigate the precision and interobserver variability of the 
20 mHz scan compared with the conventional 10 mHz B scan 
and 8 mHz A scan transducer in measuring the dimensions 
of intraocular choroidal melanoma tumors by standardized 
echography.
Methods
Twenty-seven eyes in 27 consecutive patients of vary-
ing ages were included in this prospective blinded study. 
Measurements were performed within a six-month period. 
The study was approved by the local institutional review 
board. Informed consent was obtained from all persons 
in the study. Twenty of the patients had undergone radia-
tion therapy in the past. Criteria for inclusion were uveal 
melanoma tumors not involving the iris or ciliary body. 
Each patient was examined independently three times 
by three experienced examiners within a two-week time 
frame. This protocol was chosen to avoid possible bias 
between the measurements of real tumor growth. The three 
examiners performed standardized echographic evalua-
tions independent of each other. The data were stored in 
an Excel (Microsoft Excel, Microsoft, Seattle, CA) spread 
sheet by a fourth person, therefore no examiner was aware 
of previous results. In all cases, the same instrumentation 
was used for A scan and B scan examinations (Cine Scan S, 
Quantel Medical SA, Le Brezet, France). With regard to 
the standardized echographic technique, specific criteria 
described by Ossoinig were used to evaluate intraocular 
tumor dimensions.4,7,8 All scans were performed with the 
patients placed in a supine position on a reclining chair. 
To avoid sound attenuation, particularly with the 20 mHz 
probe, the B scan probes were placed directly on the sclera, 
using a coupling gel (Methocel 2%, OmniVision GmbH, 
Puchheim, Germany). Each examination consisted of a 
preliminary topographic 10 mHz B scan evaluation.
During the first visit, the shape of the lesion and the 
measurement of both maximum transverse and longitudinal 
extension of the tumor base, as well as the tumor height with 
calipers, was performed employing the 10 mHz B scan probe. 
The direction of the patient’s gaze during measurement of 
diameter and tumor height was directly to the intraocular 
tumor, eg, if the tumor was peripherally at 12 o’clock, the 
patient was asked to look up and the B scan probe was posi-
tioned at 6 o’clock.
On the next visit, after new exploratory location of 
the tumor, the shape of the lesion, maximum transverse 
and longitudinal extensions of the tumor base, and tumor 
height were determined with calipers using the 20 mHz 
B scan probe. A relatively low gain setting was used in 
order to obtain the best measurement at both   examinations. 
  Measurements were taken of the inner sclera, which was 
identified as the first distinct line at the tumor base con-
tinuous with the surrounding fundus. Gain settings for 
B scan evaluation employing either 10 or 20 mHz were not 
specified. B scan tumor heights were measured by plac-
ing the inner caliper on the tumor surface spike once the 
tumor surface and the scleral spike were displayed in their 
maximum height during either transverse or longitudinal 
B scans. Figure 1 shows the tumor dimension measurements 
taken with the 10 mHz and 20 mHz probes. In the event of 
an existing retinal detachment, careful attention was paid 
to avoid setting the inner caliper on the surface spike of the 
tumor and not on the overlying retina.
At the third and final visit, a standardized A scan instru-
ment was first set at tissue sensitivity with the probe placed 
on the opposite site of the tumor. Careful attention was 
paid to a thorough perpendicular orientation of the sound 
beam with respect to the point of maximal tumor elevation 
and the inner sclera. Once the tumor surface spike and the 
scleral spike were displayed in their maximum height, the 
gain was lowered and the screen continuously monitored 
until the peaks were distinct and clear. Measurements 
were obtained by placing calipers on the peak of the sur-
face spike and the inner scleral spike. In the presence of 
an existing retinal detachment, careful attention was paid 
to avoid setting the inner caliper on the surface spike of 
the tumor and not on the overlying retina. At least three 
high-quality images were taken, and the photograph 
representing the most accurate measurement was finally Clinical Ophthalmology 2011:5 submit your manuscript | www.dovepress.com
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chosen by the examiner. The A scan tumor height was 
then documented.
Figure 2 shows an image of an A scan tumor height mea-
surement. Other documented parameters were shape, internal 
reflectivity, internal structure, vascularity, and location of 
the lesion. A minimum time span between examinations 
was set at two days and maximum time span over all three 
examinations at 14 days. The data were   collected using an 
Excel spread sheet (Microsoft, Redmond, WA) and analyzed 
using SPSS 12 (SPSS Inc, Chicago, IL).   Evaluations of 
measurements among the examiners were conducted using 
the Mann–Whitney U test, as well as the Wilcoxon test 
when comparing variations between the   various techniques 
of measurement. P # 0.05 was considered to be statistically 
significant.
Results
The average patient age was 64.1 (range 38–85) years. Twenty 
patients had undergone radiation therapy in the past at least 
six months earlier. Tumor heights measured with the A scan 
ranged from 1.6 to 11.6 mm, and mean tumor height for all 
patients was 4.2 mm. Three tumors were located close to 
the optic nerve, seven at the posterior pole, 14 between the 
vascular arcades and the equator, and three anterior to the 
equator but still distinguishable. In 10 cases, retinal detach-
ment above the tumor was noted   sonographically. Tumors had 
a dome-shaped configuration in 22 cases (with five tumors 
displaying an irregular surface contour) and a mushroom 
appearance in five cases. The main results of the measure-
ments obtained are summarized in Table 1. Results of tumor 
height measurements with the standardized A scan by each 
examiner tended to be higher than for both B scan measure-
ments (Figure 3). Statistical analysis revealed significant 
differences with regard to tumor height between both B scan 
techniques (10 and 20 mHz) and the A scan measurements 
(P = 0.003 for A scan versus 10 mHz B scan and P , 0.001 
for A scan versus 20 mHz B scan). No significant difference 
in tumor height was found between the two B scan techniques 
(P = 0.239, Wilcoxon test, Figure 1). In contrast, basal tumor 
diameter measurements, both transverse and longitudinal, 
Figure 1 Ultrasound images of small ocular melanoma (82-year-old female, no previous treatment). images display measurements of longitudinal and transversal diameter and 
tumor height (from left to right). Upper images show measurements with the 10 mhz B scan ultrasound transducer, lower images show the corresponding measurements 
with the 20 mhz B scan transducer.
Bio2 Q-I K
Velocity (m/s): 1550
Quantel medical cinescan S V: 5.05
B 1014 585 9
µS
Distance = 2.40 mm
Left #2 – Eye T-16.6dB
AVG height = 35%
Figure 2 A scan image of ocular melanoma (same patient as in Figure 1) measuring 
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revealed significant differences between 10 mHz and 20 mHz 
B scans (P , 0.001 and P = 0.001, respectively, Wilcoxon 
test, Figure 4). Basal diameter results for the 10 mHz 
B scan tended to be larger than in 20 mHz B scan. Evalu-
ation of measurements of diameter and height by the three 
examiners revealed no significant differences for all A scan, 
10 mHz and 20 mHz B scan techniques (P . 0.500 each, 
  Mann–Whitney U test). The mean standard deviation of the 
difference in tumor height measurements between examiners 
was ±0.24 mm for the 8 mHz A scan, ±0.46 mm for 10 mHz 
B scan, and ±0.42 mm for 20 mHz B scan. For the10 mHz B 
scan, the standard deviation was ±1.0 mm for the transverse 
and ±1.2 mm for the longitudinal base diameter, and in the 
20 mHz B scan was ±1.0 mm for the transverse and ±0.7 mm 
for the longitudinal base diameters.
To evaluate whether tumor size has any influence on 
precision of tumor height measurements, all lesions were 
categorized into three groups, ie, Group A, including tumors 
up to 3.0 mm, Group B, including tumors from 3.1 mm to 
6.0 mm, and Group C, including tumors greater than 6.0 mm 
in height. Statistical analysis again did not reveal significant 
differences in height measurements in the 8 mHz A scan, or 
10 and 20 mHz B scan, or in longitudinal and transverse basal 
diameter measurements on both B scans between the three 
examiners in all groups (P . 0.500 each, Mann–Whitney 
U test). Analogously, in Group A, statistical analysis again 
revealed no significant differences in height measurements 
between the 8 mHz A scan and both the 10 and 20 mHz 
B scans or between both B scan techniques (P $ 0.399 
each, Wilcoxon test). Contrary to these findings, in Group B, 
8 mHz A scan height measurements differed significantly as 
compared with both the 10 and 20 mHz B scans (P = 0.001 
and P = 0.007, respectively, Wilcoxon test). No significant 
difference in tumor prominence was found between either 
B scan technique (P = 0.654, Wilcoxon test). Height measure-
ments for tumors in Group C were found to be significantly 
larger in the 8 mHz A scan as compared with the 20 mHz 
B scan (P = 0.003, Wilcoxon test), but not compared with 
the 10 mHz B scan (P = 0.209, Wilcoxon test). Analogously, 
10 mHz B scan measurements differed significantly from 
those with the 20 mHz B scan (P = 0.046, Wilcoxon test) 
in this group.
Discussion
The present study is the first to compare the 20 mHz B scan 
transducer with the conventional 10 mHz B scan and 8 mHz 
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Figure 3 results of tumor height measurements with standardized A scan.
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Figure 4 results of basal tumor diameter measurements, both transverse and 
longitudinal, with the 10 mhz and 20 mhz B scan.
Table 1 results of tumor height and diameter measurements of each examiner taken with the different ultrasound probes
Examiner Tumor height (mm) Transverse basal  
diameter (mm)
Longitudinal basal  
diameter (mm)
A scan  
8 mHz 
(Ø, SD)
B scan 10  
mHz 
(Ø, SD)
B scan 20   
mHz 
(Ø, SD)
B scan 10  
mHz 
(Ø, SD)
B scan 20   
mHz 
(Ø, SD)
B scan 10  
mHz 
(Ø, SD)
B scan 20   
mHz 
(Ø, SD)
A 4.6 ± 2.4 4.4 ± 2.5 4.4 ± 2.4   9.5 ± 3.2 8.7 ± 2.4 10.3 ± 3.1   9.9 ± 2.7
B 4.8 ± 2.4 4.7 ± 2.4 4.6 ± 2.4 10.0 ± 2.6 9.3 ± 3.6 10.5 ± 2.7 10.1 ± 2.7
C 4.8 ± 2.3 4.6 ± 2.4 4.6 ± 2.3   9.7 ± 2.9 8.9 ± 2.4 10.4 ± 2.8 10.0 ± 2.8
Abbreviations: Ø, mean; sD, standard deviation.Clinical Ophthalmology 2011:5 submit your manuscript | www.dovepress.com
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A scan transducers, including interobserver variability 
analysis in measuring the dimensions of uveal melanomas 
by standardized echography.
The goal of this study was to evaluate the accuracy of the 
B scan 10 mHz and 20 mHz examination techniques when 
compared with the top-rated A scan. In standardized echogra-
phy, the A scan technique is commonly used for tumor height 
measurement, evaluation of internal structure, reflectivity, and 
signs of vascularization in the lesion.8 This information can be 
obtained solely from amplitudes, shapes, and motions of A scan 
spikes. Because there is no specific gain setting for B scan 
evaluation, the B scan is primarily used for localizing the tumor 
and gross exploratory tumor height measurement. The B scan 
can be used to measure the diameter of a lesion with gradually 
sloping edges. However, its precision is limited because this 
measurement relies strongly on signal amplification during 
the examination, but it still does provide reproducible mea-
surements for follow-up evaluation. The new 20 mHz B scan 
has advantages over the conventional 10 mHz B scan due to 
its higher resolution. This should improve the detection of 
lesion borders, thus improving the precision of   measurements. 
We found statistically significant differences in tumor height 
evaluation between both B scan methods and the A scan. The 
10 mHz and even more precise 20 mHz B scan evaluations 
underestimated tumor height. A subanalysis showed that this 
effect was especially associated with greater tumor height. This 
may be due to difficulties in detecting the lesion’s exact posi-
tion and determination of the greatest diameter, particularly in 
20 mHz B scans where only a small-diameter cross-section of 
the lesion can be seen on the screen. On the other hand, espe-
cially in tumors with subtle subretinal fluid, B scan measure-
ments may not be as precise in positioning the measurement on 
the choroidal lesion. Our findings support the recommendation 
that B scan measurements should not be considered a reliable 
method to determine tumor growth or regression. However, 
the B scan is the only method other than ophthalmoscopy 
and fundus photography to evaluate the basal diameter of a 
choroidal tumor. In addition, it provides evidence of possible 
extrascleral extension of the lesion. The main domain of the 
A scan is the measurement of tumor height. Standardization of 
the A scan ultrasound technique in terms of a “tissue sensitiv-
ity setting” allows for easy reproduction of measurements in 
contrast with the nonstandardized B scan technique.9 One of 
the main questions in the observation and initiation of appro-
priate therapy in choroidal melanoma patients is whether the 
tumor decreases in size (for example, after radiation treatment) 
or whether tumor growth is observed in smaller melanocytic 
lesions. Therefore, it is important to determine the accuracy 
of the examination   technique in terms of interobserver and 
intraobserver variability of measurements. According to our 
data, a statistical consideration should be taken into account 
when deciding on tumor growth, ie, measurements falling 
outside a 95% confidence interval are usually considered as 
a statistically reasonable indication of true change. Given a 
normal distribution of the measurements, this means that the 
measurements have to fall outside plus or minus two standard 
deviations of the measured value. Therefore, our data from 
standard deviations between different measurements suggest-
ing a difference in tumor prominence of more than 0.5 mm 
(two standard deviations) in A scan, may be considered a true 
change in tumor height, regardless of the absolute tumor height. 
Tumor shape or location did not influence the results of the 
measurements obtained in this study.
With respect to the great differences in B scan evalua-
tion of a tumor (Figures 1 and 2), neither the 20 nor 10 mHz 
B scans should be used as nonstandardized techniques for the 
definition of tumor growth. Although the 20 mHz B scan pro-
vided a higher resolution than the 10 mHz B scan, the standard 
deviation between examiners was still higher than with the A 
scan measurements. However, the B scan is still suitable for 
morphological and topographic examinations. Our standard 
deviation of 0.24 mm for each examiner is in accordance with 
data reported by other authors. Nicholson et al reported that 
approximately 90% of independent measurements by two 
technicians made from photographic records of 53 previously 
performed scans were within a 0.4 mm difference, with a stan-
dard deviation of 0.22 mm.10 A standard deviation of 0.20 mm 
for tumor height was also reported by Char et al in a prospec-
tive series of 26 patients.11   However, this study focused only 
on intraobserver variability of echographic measurements, 
and confirmed ultrasound to be the most accurate method of 
measuring tumor height. Haritoglou et al reported a standard 
deviation of 0.18 mm in A scan tumor height measurements 
in a prospective series.12
Interestingly, in all A scan and all B scan techniques, 
no statistically significant difference amongst the observ-
ers was found. This may be the result of the standardized 
approach in our institution. Furthermore, in a retrospective 
review of 32 uveal melanomas, Char et al reported a differ-
ence in ultrasound measurements of a thickness of 0.64 mm 
between two institutions (interobserver variability, range 
0–2.2 mm, standard deviation 0.60 mm), both in small and 
large tumors.13 The correlation between the two institutions 
was 0.89. According to Char et al, several factors affect these 
correlations, such as experience in ultrasound measurements, 
location of the tumor, and the instrumentation used.Clinical Ophthalmology
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However, because those two studies of interobserver 
variability were performed in a retrospective manner, they 
did not address the precision of independent measurements 
during separate dynamic echographic examinations as in our 
series, but relied on photographic evidence.10,13 In addition, 
the authors did not describe the intraobserver variability of 
echographic measurements that play an important part when a 
patient is seen by the same examiner on different occasions.
In summary, the novel 20 mHz ultrasound probe, despite 
its theoretically higher resolution, is unable to replace A scan 
measurement of tumor height. Underestimation of tumor 
height and the larger standard deviation of measurements 
lower the value of this technique in follow-up management 
of intraocular tumors.
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